Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Sigma Healthcare Ltd ( (AU:SIG) ) is now available.
Sigma Healthcare Limited reported a 41% increase in EBIT following its merger with Chemist Warehouse Group, highlighting strong growth and expanded market reach. The company upgraded its synergy target to $100 million annually within four years, reflecting operational efficiencies and cost reductions. The retail network’s performance was robust, with significant sales growth in key product categories. Sigma plans to close its physical stores in China, focusing on online sales, and optimize its distribution network by closing certain centers in Australia, aiming for improved service delivery and cost efficiency.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.30 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Limited operates in the healthcare industry, focusing on pharmaceutical distribution and retail. The company has expanded its market presence through a merger with Chemist Warehouse Group, significantly increasing its retail network across Australia and internationally.
Average Trading Volume: 30,949,984
Technical Sentiment Signal: Hold
Current Market Cap: A$33.07B
For an in-depth examination of SIG stock, go to TipRanks’ Overview page.